Cite

HARVARD Citation

    Meserve, J. et al. (n.d.). DOP006 A multicentre cohort study to assess the safety of vedolizumab for inflammatory bowel disease. Journal of Crohn's and colitis. p. S034. [Online]. 
  
Back to record